List of Excipients in API guaifenesin, pseudoephedrine hydrochloride
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing guaifenesin, pseudoephedrine hydrochloride
Detailed excipient profiles for guaifenesin, pseudoephedrine hydrochloride
Excipient focus: CARBOMER HOMOPOLYMER TYPE B
guaifenesin, pseudoephedrine hydrochloride drug variants containing CARBOMER HOMOPOLYMER TYPE B
guaifenesin, pseudoephedrine hydrochloride drug variants not containing CARBOMER HOMOPOLYMER TYPE B
Excipient focus: CELLULOSE, MICROCRYSTALLINE
guaifenesin, pseudoephedrine hydrochloride drug variants containing CELLULOSE, MICROCRYSTALLINE
guaifenesin, pseudoephedrine hydrochloride drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: COPOVIDONE K25-31
guaifenesin, pseudoephedrine hydrochloride drug variants containing COPOVIDONE K25-31
guaifenesin, pseudoephedrine hydrochloride drug variants not containing COPOVIDONE K25-31
Excipient focus: FD&C YELLOW NO. 6
guaifenesin, pseudoephedrine hydrochloride drug variants containing FD&C YELLOW NO. 6
guaifenesin, pseudoephedrine hydrochloride drug variants not containing FD&C YELLOW NO. 6
Excipient focus: FD&C YELLOW NO. 6 ALUMINUM LAKE
guaifenesin, pseudoephedrine hydrochloride drug variants containing FD&C YELLOW NO. 6 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| L Perrigo Company | guaifenesin, pseudoephedrine hydrochloride | 0113-8911 |
| WALMART INC | guaifenesin, pseudoephedrine hydrochloride | 79903-388 |
| >Company | >Ingredient | >NDC |
guaifenesin, pseudoephedrine hydrochloride drug variants not containing FD&C YELLOW NO. 6 ALUMINUM LAKE
Excipient focus: HYPROMELLOSE
guaifenesin, pseudoephedrine hydrochloride drug variants containing HYPROMELLOSE
guaifenesin, pseudoephedrine hydrochloride drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSES
guaifenesin, pseudoephedrine hydrochloride drug variants containing HYPROMELLOSES
guaifenesin, pseudoephedrine hydrochloride drug variants not containing HYPROMELLOSES
Excipient focus: MAGNESIUM STEARATE
guaifenesin, pseudoephedrine hydrochloride drug variants containing MAGNESIUM STEARATE
guaifenesin, pseudoephedrine hydrochloride drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MALTODEXTRIN
guaifenesin, pseudoephedrine hydrochloride drug variants containing MALTODEXTRIN
guaifenesin, pseudoephedrine hydrochloride drug variants not containing MALTODEXTRIN
Excipient focus: POVIDONE
guaifenesin, pseudoephedrine hydrochloride drug variants containing POVIDONE
guaifenesin, pseudoephedrine hydrochloride drug variants not containing POVIDONE
Excipient focus: SILICON DIOXIDE
guaifenesin, pseudoephedrine hydrochloride drug variants containing SILICON DIOXIDE
guaifenesin, pseudoephedrine hydrochloride drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A
guaifenesin, pseudoephedrine hydrochloride drug variants containing SODIUM STARCH GLYCOLATE TYPE A
guaifenesin, pseudoephedrine hydrochloride drug variants not containing SODIUM STARCH GLYCOLATE TYPE A
Excipient focus: STEARIC ACID
guaifenesin, pseudoephedrine hydrochloride drug variants containing STEARIC ACID
guaifenesin, pseudoephedrine hydrochloride drug variants not containing STEARIC ACID
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2026 - 2027
NCE-1 Patent Challenge Dates 2026 - 2027
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch